2015 ACR/ARHP Annual Meeting

2015 ACR/ARHP Annual Meeting | ACR 2015

The ACR/ARHP annual meeting will feature "the latest innovations, science, business and clinical best practices" in rheumatology, and enable attendees to get "first-hand access to the latest discoveries and research transforming rheumatic disease care."

Conference Coverages

Tofacitinib Effective for Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
Tofacitinib Effective for Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
In a post-hoc analysis, researchers found that the clinical efficacy of tofacitinib after 6 months of treatment was greater than placebo, and appeared similar regardless of methotrexate dose.
Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS
A review of six Phase 3 studies shows that tofacitinib is more effective for rheumatoid arthritis treatment than regimens including placebo and a disease modifying anti-rheumatic drug or methotrexate as monotherapy or in combination therapy.
Ixekizumab Effective for Biologic DMARD-naive Psoriatic Arthritis Patients
In a phase 3 study, ixekizumab showed significant, clinically meaningful improvements of disease activity and physical function for patients with psoriatic arthritis.
Baricitinib Bested Adalimumab in Rheumatoid Arthritis Trial
In patients with active rheumatoid arthritis symtoms that persisted even though they were taking methotrexate, baricitinib (Lilly/Incyte) treatment led to "significant improvements" researchers reported at the American College of Rheumatology Annual Meeting in San Francisco, CA.
Sarilumab Plus DMARD Improves Fatigue, Pain for Patients with Rheumatoid Arthritis
Patients with rheumatoid arthritis who received sarilumab plus a DMARD who did not respond to anti-TNF medications showed statistically significant and clinically meaningful changes from baseline in fatigue, morning stiffness, pain, productivity, and participation at week 24.
Secukinumab Effective in Treating Ankylosing Spondylitis
Results from the MEASURE 1 trial suggest that about 80% of patients with ankylosing spondylitis had no radiographic progression in the spine on x-ray assessment after a 2-year course of secukinumab.
Lupus: Repository Corticotropin Injection Reduces Disease Activity
Patients with persistently active systemic lupus erythematosus (SLE) benefit from repository corticotropin injection (RCI).
Plaque Psoriasis: Evaulating Il-23p19 Inhibitors
Blocking IL-23p19 with an investigational Boehringer-Ingelheim compound called BI 655066 got better results than ustekinumab (Stelara/Janssen) in patients with moderate to severe plaque psoriasis
Ozone Knee Injection Therapy Shows Promise for Osteoarthritis
Other than joint replacement, not much works in treating osteoarthritis of the knee. A Brazilian research team said it has had success with intra-articular injections of ozone.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$